StoneX Group
CLDI icon

StoneX Group’s Calidi Biotherapeutics CLDI Stock Holding History

StoneX Group’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.4K Buy
+11,311
New +$17.6K ﹤0.01% 1813

Other funds holding CLDI

Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Tradewinds Capital Management
Tradewinds Capital Management Bellingham, Washington $578M AUM 35.02% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

StoneX Group's CLDI Position: Q3 2026 in Review

StoneX Group opened a new position in Calidi Biotherapeutics (CLDI) in Q3 2026: 11,311 shares worth $13.4K. The stake represents ﹤0.01% of the portfolio and ranks #1813 among its holdings.

5 funds tracked by Wall St. Rank hold CLDI as of Q3 2026.

  • StoneX Group held 11,311 shares of Calidi Biotherapeutics worth $13.4K as of Q3 2026.
  • Calidi Biotherapeutics was a new StoneX Group position in Q3 2026.
  • Calidi Biotherapeutics made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1813 holding.
  • 5 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.